Arialys Therapeutics announced Tuesday that it tied the bow on a $58 million seed round to develop treatments specifically for brain disorders caused by immune reactions. Endpoints News reported in December that the CNS biotech […]
Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ — Mati Therapeutics Inc. (“Mati”) announced that it has completed and now […]
The FDA’s Cardiovascular and Renal Drugs Advisory Committee will meet tomorrow to discuss the efficacy of Alnylam’s Onpattro (patisiran) for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. While Alnylam […]
ActivatedYou Morning Complete Supports Overall Well-Being With Eight Unique Wellness Blends LOS ANGELES, Sept. 12, 2023 /PRNewswire/ — Morning Complete® by Maggie Q’s ActivatedYou® has now received over 3000 positive reviews across various platforms. This […]
Dr. Catherine Fillmore and Dr. Nichole Siripon to join Kidstown Dental in Katy, Texas KATY, Texas, Sept. 12, 2023 /PRNewswire/ — Kidstown Dental announced today the addition of two highly skilled and compassionate dentists in […]
A new fund in the Triangle is raising money to support life sciences companies that are developing drugs and other products aimed at addressing antimicrobial resistance. Click here to view original post Click here to […]
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)– #HealthDataCloud–DNAnexus announced that Thomas Laur has been appointed Chief Executive Officer and member of the company’s Board of Directors. Click here to view original post Click here to view San Francisco […]
FREDERICK, Md.–(BUSINESS WIRE)–Maryland Life Sciences, a division of the Maryland Tech Council, today announced a packed agenda and roster of top speakers for the 2023 Bio Innovation Conference to be held Monday, October 30, in […]
LA JOLLA, Calif.–(BUSINESS WIRE)– #autoantibodies–Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric Diseases Click here to view original post Click here to view San Diego Biotech Networks Trending News
Replicate Bioscience, a biotech startup designing next-generation mRNA vaccines to trigger stronger and longer-lasting immune responses, has begun its first clinical study, the San Diego company announced Tuesday. The trial, which comes two years after […]
© 2023 Biotech Networks, LLC
